Di Paola R, et al. - This retrospective analysis was conducted to assess the potential application of a nomogram based on a woman’s age and ovarian reserve markers to optimize the follicle-stimulating hormone (FSH) starting dose in intrauterine insemination (IUI) cycles. They analyzed data of 179 infertile women undergoing controlled ovarian stimulation, followed by IUI. They found that, although it did not seem adequate in women with polycystic ovary syndrome—particularly those with high anti-Müllerian hormone levels, there was evidence to suggest that the application of this nomogram in IUI cycles would lead to a more tailored FSH starting dose and improved cost-effectiveness.